Literature DB >> 12785247

The Adult Memory and Information Processing Battery (AMIPB) test of information-processing speed: a study of its reliability and feasibility in patients with multiple sclerosis.

A M M Vlaar1, D T Wade.   

Abstract

OBJECTIVE: To investigate how useful the Adult Memory and Information Processing Battery Task A (AMIPB) is as a test of the speed of information processing in patients with multiple sclerosis (MS) by comparing various methods of presenting the test and assessing the reliability (test-retest and inter-rater) and utility of each version.
DESIGN: Each patient was assessed twice verbally by the same assessor 1-2 weeks apart. Then 1-2 weeks later half were assessed by another observer, and half were assessed by the first observer using a written method.
SETTING: A specialist young disabled unit.
SUBJECTS: Thirty-three patients with MS. MEASURES: The AMIPB, the Short Memory-Orientation-Concentration Test (SOMC) and the Barthel ADL Index.
RESULTS: The average (SD) number of correct responses after 4 min was 23.3 (18.6), median 21. The test-retest reliability (n = 24) of the 4-min AMIPB was high (r = 0.98) and the difference of the score ranged from -7 to 9: median 3, mean (SD) 1.88 (4.01) and interquartile range 0 to 3.25. The inter-observer reliability (n = 12) of the 4-min AMIPB was also high (r = 0.97) and the mean (SD) differences between scores were 4.3 (5.8), median 4, range +19 to -2. The score at 60 seconds and the score at 240 seconds were highly correlated (r = 0.98). The scores obtained verbally and by writing were closely correlated (r = 0.99).
CONCLUSIONS: The AMIPB used over 120 seconds with verbal responses is a reliable and reasonable test for major information-processing deficits.

Entities:  

Mesh:

Year:  2003        PMID: 12785247     DOI: 10.1191/0269215503cr625oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  4 in total

1.  Impact of At Least 2 Years of Synthetic Cannabinoid Use on Cognitive and Psychomotor Functions Among Treatment-Seeking Male Outpatients.

Authors:  Gokhan Umut; Cuneyt Evren; Murat Ilhan Atagun; Ozge Hisim; Hanife Yilmaz Cengel; Muge Bozkurt; Cahit Keskinkilic
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

2.  A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS).

Authors:  S Coe; J Collett; H Izadi; D T Wade; M Clegg; J M Harrison; E Buckingham; A Cavey; G C DeLuca; J Palace; H Dawes
Journal:  Pilot Feasibility Stud       Date:  2018-01-23

3.  Assessment of neuropsychological function in brain tumor treatment: a comparison of traditional neuropsychological assessment with app-based cognitive screening.

Authors:  Rafael Romero-Garcia; Mallory Owen; Alexa McDonald; Emma Woodberry; Moataz Assem; Pedro Coelho; Rob C Morris; Stephen J Price; Tom Santarius; John Suckling; Tom Manly; Yaara Erez; Michael G Hart
Journal:  Acta Neurochir (Wien)       Date:  2022-03-01       Impact factor: 2.816

4.  Activity and Life After Survival of a Cardiac Arrest (ALASCA) and the effectiveness of an early intervention service: design of a randomised controlled trial.

Authors:  Véronique R M P Moulaert; Jeanine A Verbunt; Caroline M van Heugten; Wilbert G M Bakx; Anton P M Gorgels; Sebastiaan C A M Bekkers; Marc C F T M de Krom; Derick T Wade
Journal:  BMC Cardiovasc Disord       Date:  2007-08-27       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.